Cargando…

Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway

OBJECTIVE: Sijunzi, Lizhong, and Fuzilizhong decoction were traditional Chinese classic formulations, which are widely used in clinical treatment, and the underlying mechanism is unclear. In this study, we aim to investigate the molecular mechanisms underlying the protective effects of Sijunzi, Lizh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiayao, Tao, Dongqing, Ma, Wei, Liu, Song, Liao, Yan, Shu, Lei, Zhang, Shu, Li, Chenyu, Du, Nianlong, Shi, Zhaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648686/
https://www.ncbi.nlm.nih.gov/pubmed/33178320
http://dx.doi.org/10.1155/2020/6363748
_version_ 1783607162344308736
author Yang, Jiayao
Tao, Dongqing
Ma, Wei
Liu, Song
Liao, Yan
Shu, Lei
Zhang, Shu
Li, Chenyu
Du, Nianlong
Shi, Zhaohong
author_facet Yang, Jiayao
Tao, Dongqing
Ma, Wei
Liu, Song
Liao, Yan
Shu, Lei
Zhang, Shu
Li, Chenyu
Du, Nianlong
Shi, Zhaohong
author_sort Yang, Jiayao
collection PubMed
description OBJECTIVE: Sijunzi, Lizhong, and Fuzilizhong decoction were traditional Chinese classic formulations, which are widely used in clinical treatment, and the underlying mechanism is unclear. In this study, we aim to investigate the molecular mechanisms underlying the protective effects of Sijunzi, Lizhong, and Fuzilizhong on nonalcoholic fatty liver disease (NAFLD). METHODS: Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD and were thereafter administered Sijunzi (8 g/kg/d), Lizhong (10 g/kg/d), or Fuzilizhong (10 g/kg/d) by gavage for four weeks. Hepatic damage, lipid accumulation, inflammation, autophagy, and peroxisome proliferator-activated receptor-α signaling were evaluated. RESULTS: The high-fat diet-fed rats showed typical symptoms of NAFLD, including elevated levels of hepatic damage indicators, increased hepatic lipid deposition and fibrosis, severe liver inflammation, and prominent autophagy. Upon administration of Sijunzi, Lizhong, and Fuzilizhong, liver health was improved remarkably, along with ameliorated symptoms of NAFLD. In addition, NAFLD-suppressed peroxisome proliferator-activated receptor-α signaling was reactivated after treatment with the three types of decoctions. CONCLUSIONS: The results collectively signify the effective therapeutic and protective functions of Sijunzi, Lizhong, and Fuzilizhong against NAFLD and demonstrate the potential of Chinese herbal medication in mitigating the symptoms of liver diseases. Novelty of the Work. Traditional Chinese herbal medicine has been used for centuries to treat various diseases, but the molecular mechanisms of individual ingredients have rarely been studied. The novelty of our work lies in elucidating the specific signaling pathways involved in the control of NAFLD using three common Chinese herbal decoctions. We suggest that natural herbal formulations can be effective therapeutic agents to combat against NAFLD.
format Online
Article
Text
id pubmed-7648686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76486862020-11-10 Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway Yang, Jiayao Tao, Dongqing Ma, Wei Liu, Song Liao, Yan Shu, Lei Zhang, Shu Li, Chenyu Du, Nianlong Shi, Zhaohong Evid Based Complement Alternat Med Research Article OBJECTIVE: Sijunzi, Lizhong, and Fuzilizhong decoction were traditional Chinese classic formulations, which are widely used in clinical treatment, and the underlying mechanism is unclear. In this study, we aim to investigate the molecular mechanisms underlying the protective effects of Sijunzi, Lizhong, and Fuzilizhong on nonalcoholic fatty liver disease (NAFLD). METHODS: Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD and were thereafter administered Sijunzi (8 g/kg/d), Lizhong (10 g/kg/d), or Fuzilizhong (10 g/kg/d) by gavage for four weeks. Hepatic damage, lipid accumulation, inflammation, autophagy, and peroxisome proliferator-activated receptor-α signaling were evaluated. RESULTS: The high-fat diet-fed rats showed typical symptoms of NAFLD, including elevated levels of hepatic damage indicators, increased hepatic lipid deposition and fibrosis, severe liver inflammation, and prominent autophagy. Upon administration of Sijunzi, Lizhong, and Fuzilizhong, liver health was improved remarkably, along with ameliorated symptoms of NAFLD. In addition, NAFLD-suppressed peroxisome proliferator-activated receptor-α signaling was reactivated after treatment with the three types of decoctions. CONCLUSIONS: The results collectively signify the effective therapeutic and protective functions of Sijunzi, Lizhong, and Fuzilizhong against NAFLD and demonstrate the potential of Chinese herbal medication in mitigating the symptoms of liver diseases. Novelty of the Work. Traditional Chinese herbal medicine has been used for centuries to treat various diseases, but the molecular mechanisms of individual ingredients have rarely been studied. The novelty of our work lies in elucidating the specific signaling pathways involved in the control of NAFLD using three common Chinese herbal decoctions. We suggest that natural herbal formulations can be effective therapeutic agents to combat against NAFLD. Hindawi 2020-10-29 /pmc/articles/PMC7648686/ /pubmed/33178320 http://dx.doi.org/10.1155/2020/6363748 Text en Copyright © 2020 Jiayao Yang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Jiayao
Tao, Dongqing
Ma, Wei
Liu, Song
Liao, Yan
Shu, Lei
Zhang, Shu
Li, Chenyu
Du, Nianlong
Shi, Zhaohong
Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_full Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_fullStr Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_full_unstemmed Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_short Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_sort sijunzi, lizhong, and fuzilizhong decoction alleviate nonalcoholic fatty liver disease through activation of ppar pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648686/
https://www.ncbi.nlm.nih.gov/pubmed/33178320
http://dx.doi.org/10.1155/2020/6363748
work_keys_str_mv AT yangjiayao sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT taodongqing sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT mawei sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT liusong sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT liaoyan sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT shulei sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT zhangshu sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT lichenyu sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT dunianlong sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT shizhaohong sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway